Abcellera Biologics Inc Revenue per Employee (ABCL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abcellera Biologics Inc   (NASDAQ: ABCL)
 

Abcellera Biologics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 18.81% in the third quarter 2026, year on year to cumulative value of $68 million, Abcellera Biologics Inc 's revenue per employee grew on a trailing twelve months basis to $ 120,744, this is below the company average.
Within the Healthcare sector Employees of 441 other companies have achieved higher revenue per employee. While Abcellera Biologics Inc 's total ranking has deteriorated compared to the previous quarter from 2456 to 3262. Abcellera Biologics Inc has 562 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABCL Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 18.81 % -76.29 % 96.34 % 788.37 % 37.62 %
Sales per Employee (TTM) $ 120,744 117,747 140,940 133,680 62,852
ABCL's Total Ranking # 3262 # 2456 # 1471 # 2071 #
Seq. Revenue Change 162.69 % -51.29 % -81.46 % 400.88 % -47.58 %

ABCL Company Profile >> Back to ABCL Efficiency Comparisons >> Compare ABCL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 442
Overall Market # 3262

Revenue per Employee Statistics
High Average Low
$ 1,073,295 $ 313,167 $ 41,128
(Sep 30 2022)   (Mar 31 2025)



Financial Statements
Abcellera Biologics Inc 's Revenue MRQ $ 11 Millions Visit ABCL's Income Statement
Abcellera Biologics Inc 's Revenues TTM $ 68 Millions Visit ABCL's aggregate revenue growth
What are ABCL's Sales? Visit ABCL's Sales by Segment




Other Ratios
Abcellera Biologics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABCL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABCL's Competitors
Revenue per Employee for ABCL's Suppliers
Revenue per Employee for ABCL's Customers

You may also want to know
ABCL's Sales Growth Rates ABCL's Pe Price to earnings ratio ABCL's Receivables Turnover Ratio ABCL's Stock Quote
ABCL's Net Income Growth Rates ABCL's Ps Price to Sales ratio ABCL's Sales per Employee ABCL's Asset Turnover Ratio
ABCL's Net Margin ABCL's Pb Price to Book ratio ABCL's Financial Strength Ratios ABCL's Dividend Payout Ratio
Date modified: 2026-11-10T11:44:37+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Labcorp Holdings Inc   208,492.86 $ 14,594.500  Million 70,000 
Quest Diagnostics Inc  207,736.84 $ 11,841.000  Million 57,000 
Pacific Health Care Organization Inc  205,413.39 $ 6.368  Million 31 
Cytomx Therapeutics Inc   203,289.86 $ 14.027  Million 69 
Fortrea Holdings Inc   186,482.52 $ 2,666.700  Million 14,300 
Abeona Therapeutics Inc   185,451.33 $ 41.912  Million 226 
Iqvia Holdings Inc   182,221.05 $ 17,311.000  Million 95,000 
Davita Inc   181,635.19 $ 14,167.545  Million 78,000 
Voyager Therapeutics Inc   178,070.92 $ 25.108  Million 141 
Chemed Corporation  168,303.14 $ 2,661.041  Million 15,811 
Icu Medical Inc  167,965.85 $ 2,183.556  Million 13,000 
Stoke Therapeutics Inc   165,947.06 $ 28.211  Million 170 
Integer Holdings Corporation  165,920.18 $ 1,825.122  Million 11,000 
Lifestance Health Group Inc   152,986.86 $ 1,676.889  Million 10,961 
Encompass Health Corporation  150,907.14 $ 6,338.100  Million 42,000 
Profound Medical Corp   145,845.68 $ 23.627  Million 162 
Intellia Therapeutics Inc   140,283.82 $ 52.887  Million 377 
Crispr Therapeutics Ag  125,233.83 $ 25.172  Million 201 
Sonida Senior Living Inc   124,149.81 $ 638.130  Million 5,140 
Ensign Group Inc  123,354.46 $ 5,674.305  Million 46,000 
Abcellera Biologics Inc   120,743.77 $ 67.858  Million 562 
Pacs Group Inc   120,220.19 $ 5,705.049  Million 47,455 
U S Physical Therapy Inc  114,838.09 $ 837.629  Million 7,294 
Recursion Pharmaceuticals Inc   113,720.00 $ 68.232  Million 600 
Amarin Corp Plcuk  107,035.76 $ 176.609  Million 1,650 
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.